BASILEA PHARMACEUTICA AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.95 CHF | +0.23% |
|
+7.64% | +21.67% |
| May. 03 | Basilea Reports Presentation of New Data for Ceftobiprole (Zevtera®) At Escmid Global 2024 | CI |
| Apr. 09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BASILEA PHARMACEUTICA AG | Other Biotechnology & Medical Research | +0.23% | +7.64% | +21.67% | -6.53% | +3.20% | 572M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- BSLN Stock
- Charts Basilea Pharmaceutica AG
- Comparison Chart
